• Earnings Per Share (EPS) of $1.62, surpassing estimates and indicating strong growth in the Marketplace business line.
• Revenue reached approximately $42 billion, a 10.5% increase year-over-year, driven by growth in membership rolls and premium and service revenue.
• Despite challenges, Centene's financial structure remains balanced with a debt-to-equity ratio of approximately 0.64, and it has raised its annual outlook.

Centene Corporation, listed as NYSE:CNC, is a prominent player in the managed care and health insurance industry. The company focuses on providing services to government-sponsored healthcare programs. Centene competes with other major health insurers like UnitedHealth Group and Anthem. On October 25, 2024, Centene reported impressive financial results, which had a significant impact on its stock performance.

Centene's earnings per share (EPS) for the third quarter were $1.62, surpassing the estimated $1.36. This strong performance was driven by growth in its Marketplace business line, as highlighted by the increase in premiums due to strong product positioning. Despite a negative price-to-earnings (P/E) ratio of -1.5, Centene's stock surged over 10% on Friday morning, reflecting investor confidence in its financial results.

The company reported revenue of approximately $42 billion, exceeding the estimated $37.9 billion. This 10.5% increase compared to the previous year was fueled by growth in membership rolls and an increase in premium and service revenue. Centene's price-to-sales ratio of about 0.21 suggests a relatively low market valuation compared to its revenue, indicating potential for future growth.

Despite the positive revenue figures, Centene faced challenges with a decline in Medicaid membership and increased expenses, impacting its profitability. The company's enterprise value to operating cash flow ratio of approximately 38.42 provides insight into how the market values its cash flow generation capabilities. Centene's debt-to-equity ratio of approximately 0.64 indicates a moderate level of debt relative to its equity, reflecting a balanced financial structure.

Centene has expressed confidence in capturing long-term growth within the government-sponsored healthcare sector and has raised its annual outlook. The company's current ratio of around 1.10 suggests a slightly higher level of current assets compared to its current liabilities, indicating its short-term financial health. With an earnings yield of about 9.15%, Centene offers a perspective on the return on investment from its earnings, further supporting its strong market position.